| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $333K | — | +264.5% |
| SG&A Expense | $1.7M | — | +168.7% |
| Operating Income | -$2.0M | — | -181.1% |
| Interest Expense | $3K | — | -1.2% |
| Net Income | -$2.0M | — | -180.1% |
| EPS (Basic) | -$0.18 | — | +37.9% |
| EPS (Diluted) | -$0.18 | — | +37.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $3.4M | -34.2% | — |
| Total Assets | $10.9M | -14.7% | +617.5% |
| Current Liabilities | $1.2M | -8.1% | +245.0% |
| Total Liabilities | $1.7M | -4.8% | — |
| Stockholders' Equity | $7.9M | -17.8% | +585.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.8M | — | -222.1% |
| Investing Cash Flow | -$25K | — | — |
| Financing Cash Flow | $914K | — | +0.0% |